Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis
Mostard, R L M × Vöö, S van Kroonenburgh, M J P G Verschakelen, Johny Wijnen, P A H M Nelemans, P Erckens, R Drent, M #
Baillière Tindall, in association with the British Thoracic Society
Respiratory Medicine vol:105 issue:12 pages:1917-1924
Establishing inflammatory activity in sarcoidosis patients with persistent disabling symptoms is important. Whole body F(18)-FDG PET/CT (PET) appeared to be a sensitive method to detect inflammatory activity in newly diagnosed symptomatic sarcoidosis. The aim was to assess the presence of inflammatory activity using PET in sarcoidosis patients with unexplained persistent disabling symptoms and the association between PET findings and serological inflammatory markers.